Skatrud P L
Lilly Research Labs., Lilly Corporate Center, Indianapolis, IN 46285.
Trends Biotechnol. 1992 Sep;10(9):324-9. doi: 10.1016/0167-7799(92)90258-w.
Recombinant DNA technology has facilitated a rapid increase in our knowledge of beta-lactam antibiotic biosynthesis. Using the tools of this technology, beta-lactam biosynthetic genes and proteins have been characterized at the molecular level, cephalosporin-C production has been improved, new beta-lactams produced, and novel beta-lactam biosynthetic pathways have been constructed.